Nature. 1994 Dec 8;372(6506):485. doi: 10.1038/372485a0.
Two decisions by the British Appeal Court raise questions about the allowable breadth of biotechnology patents, but point to the charges patent-holders should be free to make.
英国上诉法院的两项裁决引发了关于生物技术专利可允许的保护范围的问题，但也指出了专利持有人应可自由进行的收费行为。
